@article{article, title  = {{Pembrolizumab for locally advanced or metastatic urothelial cancer where cisplatin is unsuitable: an evidence review group perspective of a NICE single technology appraisal}},

 publisher = {{Springer Nature}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/141166 }},

 year = {{2019}},

 month = {{9}},

 author = {{Ren S and Squires H and Hock E and Kaltenthaler E and Rawdin A and Alifrangis C}},

 doi = {{10.1007/s40273-018-0750-2}},

 volume = {{37}},

 journal = {{PharmacoEconomics}},

 issue = {{9}},

 pages = {{1073-1080}},

 note = {{Accessed on 2025/10/31}}}